258 related articles for article (PubMed ID: 14726380)
21. A high efficient FVIII variant corrects bleeding in hemophilia A mouse model.
Mashausi DS; Roy D; Mangukiya HB; Merugu SB; Raza G; Yunus FU; Liu GS; Negi H; Li D
Biochem Biophys Res Commun; 2022 Dec; 637():358-364. PubMed ID: 35595575
[TBL] [Abstract][Full Text] [Related]
22. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
Ogata K; Selvaraj SR; Miao HZ; Pipe SW
J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
[TBL] [Abstract][Full Text] [Related]
23. [vWF improves secretion and activity of intein spliced BDD-FVIII].
Zhu FX; Yang SD; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2010 May; 45(5):595-600. PubMed ID: 20931761
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.
Spencer HT; Denning G; Gautney RE; Dropulic B; Roy AJ; Baranyi L; Gangadharan B; Parker ET; Lollar P; Doering CB
Mol Ther; 2011 Feb; 19(2):302-9. PubMed ID: 21081907
[TBL] [Abstract][Full Text] [Related]
25. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.
Wei W; Zheng C; Zhu M; Zhu X; Yang R; Misra S; Zhang B
Sci Rep; 2017 Mar; 7():45033. PubMed ID: 28327546
[TBL] [Abstract][Full Text] [Related]
26. Roles of phytanoyl-CoA alpha-hydroxylase in mediating the expression of human coagulation factor VIII.
Chen C; Wang Q; Fang X; Xu Q; Chi C; Gu J
J Biol Chem; 2001 Dec; 276(49):46340-6. PubMed ID: 11574539
[TBL] [Abstract][Full Text] [Related]
27. Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII).
Zheng C; Page RC; Das V; Nix JC; Wigren E; Misra S; Zhang B
J Biol Chem; 2013 Jul; 288(28):20499-509. PubMed ID: 23709226
[TBL] [Abstract][Full Text] [Related]
28. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
Zhu F; Liu Z; Miao J; Qu H; Chi X
Sci China Life Sci; 2012 Jun; 55(6):521-6. PubMed ID: 22744182
[TBL] [Abstract][Full Text] [Related]
29. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.
Mannully ST; L N R; Pulicherla KK
Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930
[TBL] [Abstract][Full Text] [Related]
30. Functional identification of factor VIII B domain regions in hepatocyte cells.
Jun Z; Ming-Ming L; Qian-Qing Z; Yun-Hong W; Chong-Yang Z; Xin L
Biochem Biophys Res Commun; 2020 Jun; 526(3):633-640. PubMed ID: 32248973
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.
Wei W; Misra S; Cannon MV; Yang R; Zhu X; Gilmore R; Zhu M; Zhang B
Biochem J; 2018 Mar; 475(5):873-886. PubMed ID: 29444815
[TBL] [Abstract][Full Text] [Related]
32. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
Marquette KA; Pittman DD; Kaufman RJ
J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
[TBL] [Abstract][Full Text] [Related]
33. Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion.
Jiang N; Xiao Y; Liu Y; Liu W; Liu S
Exp Cell Res; 2020 Dec; 397(1):112334. PubMed ID: 33144078
[TBL] [Abstract][Full Text] [Related]
34. Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.
Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Kempton CL; Doering CB; Lollar P
Blood; 2011 Mar; 117(11):3190-8. PubMed ID: 21217077
[TBL] [Abstract][Full Text] [Related]
35. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins.
Lei TC; Scott DW
Blood; 2005 Jun; 105(12):4865-70. PubMed ID: 15769892
[TBL] [Abstract][Full Text] [Related]
36. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
Kang Y; Xie L; Tran DT; Stein CS; Hickey M; Davidson BL; McCray PB
Blood; 2005 Sep; 106(5):1552-8. PubMed ID: 15886327
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of recombinant ovine coagulation factor VIII.
Zakas PM; Gangadharan B; Almeida-Porada G; Porada CD; Spencer HT; Doering CB
PLoS One; 2012; 7(11):e49481. PubMed ID: 23152911
[TBL] [Abstract][Full Text] [Related]
38. The tertiary structure and domain organization of coagulation factor VIII.
Shen BW; Spiegel PC; Chang CH; Huh JW; Lee JS; Kim J; Kim YH; Stoddard BL
Blood; 2008 Feb; 111(3):1240-7. PubMed ID: 17965321
[TBL] [Abstract][Full Text] [Related]
39. Expression of factor VIII in recombinant and transgenic systems.
Soukharev S; Hammond D; Ananyeva NM; Anderson JA; Hauser CA; Pipe S; Saenko EL
Blood Cells Mol Dis; 2002; 28(2):234-48. PubMed ID: 12064919
[TBL] [Abstract][Full Text] [Related]
40. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
